Oncology Institute Inc (TOI) — Capital Reinvestment Ratio
Oncology Institute Inc (TOI) has a Capital Reinvestment Ratio of 0.33x as of December 2025, meaning it reinvests 0% of its operating cash flow ($3.23 Million) in capital expenditures ($1.06 Million). See net asset quality index of Oncology Institute Inc to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Oncology Institute Inc Capital Reinvestment Ratio (2018–2020)
This chart tracks Oncology Institute Inc's Capital Reinvestment Ratio across 3 annual periods. Check TOI capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Oncology Institute Inc (2018–2020)
Year-by-year Capital Reinvestment Ratio for Oncology Institute Inc from 2018 to 2020. For live market cap and broader valuation context, see TOI company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 2.35x | $508.00K | $1.19 Million | ▲ +605.4% |
| 2019 | 0.33x | $3.62 Million | $1.20 Million | ▲ +170.1% |
| 2018 | 0.12x | $5.64 Million | $695.96K | — |